Treatment of Depression in Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Depression
Interventions
DRUG

Escitalopram

Participants will receive escitalopram for a minimum of 32 weeks or approximately 8 months. Participants whose symptoms become stabilized will continue the initial treatment for another 6 months.

BEHAVIORAL

Interpersonal Psychotherapy

Participants will receive interpersonal psychotherapy (IPT) for 8 months and possibly an additional 6 months.

OTHER

Escitalopram plus IPT

Participants whose symptoms become stabilized will continue the initial treatment for another 6 months. Those who do not will have the second treatment added to their regimen until remission occurs.

Trial Locations (2)

15213

Western Psychiatric Institute and Clinic - Depression Prevention Program, Pittsburgh

Unknown

The University of Pisa, Pisa

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Pittsburgh

OTHER

NCT00073697 - Treatment of Depression in Adults | Biotech Hunter | Biotech Hunter